Moderna (NASDAQ: MRNA) reported Q3 EPS of $0.03, $1.95 better than the analyst estimate of ($1.92). Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.24 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.